AORT Similar Chart Price Prediction
The price of AORT is predicted to go up 4.86%, based on the high correlation periods with CRVL. The similarity of these two price pattern on the periods is 95.63%.
AORT
CRVL
Up: 4.86%Similarity: 95.63%
AORT Revenue Forecast
AORT EPS Forecast
AORT FAQs
What is revenue forecast for next quarter？
AORT Analyst's Forecast
Daniel Stauder
JMP Securities
Buy
Price Target
$33
Upside
+22.86%
JMP Securities initiated coverage of Artivion with an Outperform rating and $33 price target. Artivion is a cardiovascular-focused medical technologies company with leading aortic-centric solutions, including valve replacements and stent grafts for treating dissections and aneurysms, the analyst tells investors in a research note. The firm views the company as a "unique small cap name worth owning," citing its "dependable" base business, complementary advanced stent graft division, EBITDA growth and margin profile, and potential upside from "notable shots on goal slated for the years ahead."